Insider · CIK 0001798733
Sharon Szafranski
officerdirector
Files at ITW (ILLINOIS TOOL WORKS INC), ITT (ITT INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ITW ILLINOIS TOOL WORKS INC | MOption exercise Common Stock | +2,098 | $0.00 | $0 | 9,294 | Feb 17, 2026 |
| Feb 12, 2026 | ITW ILLINOIS TOOL WORKS INC | FTax withholding Common Stock | -631 | $298.51 | $188k | 8,663 | Feb 17, 2026 |
| Feb 12, 2026 | ITW ILLINOIS TOOL WORKS INC | MOption exercise Performance Share Units (granted 2/10/23)derivative | -2,098 | $0.00 | $0 | 0 | Feb 17, 2026 |
| Feb 13, 2026 | ITW ILLINOIS TOOL WORKS INC | AGrant or award Employee Stock Optionderivative | +10,120 | $0.00 | $0 | 10,120 | Feb 17, 2026 |
| May 21, 2025 | ITT ITT INC. | AGrant or award Common Stock | +1,040 | $0.00 | $0 | 2,552 | May 23, 2025 |
| Feb 13, 2025 | ITW ILLINOIS TOOL WORKS INC | MOption exercise Common Stock | +1,898 | - | - | 7,768 | Feb 18, 2025 |
| Feb 13, 2025 | ITW ILLINOIS TOOL WORKS INC | FTax withholding Common Stock | -572 | $260.09 | $149k | 7,196 | Feb 18, 2025 |
| Feb 13, 2025 | ITW ILLINOIS TOOL WORKS INC | MOption exercise Performance Share Units (granted 2/11/22)derivative | -1,898 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 14, 2025 | ITW ILLINOIS TOOL WORKS INC | AGrant or award Employee Stock Optionderivative | +10,421 | $0.00 | $0 | 10,421 | Feb 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.